Aplenzin and Ambien drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aplenzin (bupropion hydrobromide) and Ambien (zolpidem tartrate). Common drug interactions include balance disorder among females and hepatic enzyme increased among males.

The phase IV clinical study analyzes what interactions people have when they take Aplenzin and Ambien. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Aplenzin?

Aplenzin has active ingredients of bupropion hydrobromide. It is often used in depression. eHealthMe is studying from 396 Aplenzin users. Check the latest studies of Aplenzin.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.



On Jul, 26, 2026

14 people who take Aplenzin and Ambien together, and have interactions are studied.

Aplenzin and Ambien drug interactions.

What are the common drug interactions of Aplenzin and Ambien, by gender? *:

female:

  1. Balance disorder
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Gait disturbance
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Attention deficit/hyperactivity disorder
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Burning sensation
  8. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  9. Compulsions (performing an act persistently and repetitively)
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Hepatic enzyme increased
  2. Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)

What are the common drug interactions of Aplenzin and Ambien, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Attention deficit/hyperactivity disorder
  3. Burning sensation
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Cough
  6. Crying
  7. Dysstasia (difficulty in standing)
  8. Fatigue (feeling of tiredness)
  9. Feeling of body temperature change
  10. Gastric disorder (disease of stomach)

50-59:

  1. Abnormal dreams
  2. Anxiety
  3. Balance disorder
  4. Crying
  5. Drug ineffective
  6. Dyskinesia (abnormality or impairment of voluntary movement)
  7. Gait disturbance
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  5. Drug ineffective
  6. Dry mouth
  7. Dry throat
  8. Erythema (redness of the skin)
  9. Joint swelling
  10. Swelling face

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 35.71%
  2. Stress And Anxiety: 5 people, 35.71%
  3. Infection: 4 people, 28.57%
  4. Asthma: 4 people, 28.57%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 28.57%
  6. Hypokalemia (low potassium): 3 people, 21.43%
  7. Arrhythmias (irregular heartbeat): 3 people, 21.43%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 21.43%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 21.43%
  10. Cough: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Aplenzin and Ambien?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aplenzin and Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aplenzin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aplenzin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrobromide and zolpidem tartrate (the active ingredients of Aplenzin and Ambien, respectively), and Aplenzin and Ambien (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: